Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARD · NASDAQ Global Select
+$0.09 today
Vol 0.14M · Avg 0.18M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-70.52%
Period High
$17.41
Period Low
$3.48
Latest
$3.93
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Assembly Biosciences, Inc.
NASDAQ:ASMB
$391.88M
Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
$294.85M
Nautilus Biotechnology, Inc.
NASDAQ:NAUT
$278.94M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
$243.08M
Zura Bio Limited
NASDAQ:ZURA
$240.96M
Eupraxia Pharmaceuticals Inc.
NASDAQ:EPRX
$210.92M
Avalo Therapeutics, Inc.
NASDAQ:AVTX
$170.65M
Caribou Biosciences, Inc.
NASDAQ:CRBU
$161.66M
Pyxis Oncology, Inc.
NASDAQ:PYXS
$127.03M
Tenaya Therapeutics, Inc.
NASDAQ:TNYA
$117.86M
What is the latest AARD filing?
The latest filing shown is 8-K dated Jun 12, 2026.
How many recent filings does AARD have?
Intrinsic Alpha currently shows 20 recent filings for AARD.
Explore More
Continue the stock analysis
Jump to another research area for this company.